April 4, 2026
Tag: Cancer Genetics Research Program
April 3, 2026
UNC Lineberger and UNC faculty and trainees scheduled to present findings at American Association of Cancer Research Annual Meeting
UNC Lineberger researchers will present findings, chair sessions, lead session discussions and share their perspectives in topical forums and education sessions during the AACR Annual Meeting.
January 6, 2026
UNC researchers show combination therapy effective for brain cancer
The research, led by Nobel laureate and biochemist Aziz Sancar, MD, PhD, could revolutionize treatments for glioblastoma, an aggressive and deadly form of brain cancer.
December 1, 2025
Priming the pump for new cancer treatments
UNC Eshelman School of Pharmacy’s Chemical Biology and Medicinal Chemistry Division is a central hub for cancer therapeutics. Its faculty members are studying the chemical and biological mechanisms that promote cancer growth and persistence.
November 1, 2025
UNC researchers unlock new way to help fight skin cancer
Researchers found that inhibiting a problematic protein in the body helps immunotherapies and CAR-T therapy to better fight off melanoma.
October 31, 2025
UNC Lineberger continues its national leadership in breast cancer research
UNC Lineberger researchers are leading next-generation clinical breast cancer trials as part of a national project using cutting-edge technologies to track tumor changes in real time.
October 7, 2025
Researchers awarded $11.2M grant to close endometrial cancer survival gap
The National Cancer Institute has awarded a Cancer Health Disparities Specialized Program of Research Excellence (SPORE) in Endometrial Cancer grant to UNC Lineberger's Victoria Bae-Jump, MD, PhD, and Hazel Nichols, PhD.
August 26, 2025
Ramsden receives Battle Award for groundbreaking genome stability research
Dale Ramsden, PhD, was presented with the Battle Award for his research on how cells repair DNA double-strand breaks, a critical process for maintaining genome stability and preventing cancer-causing mutations.
August 21, 2025
Urology Times: Kathryn Gessner, MD, discusses her use of genomic testing in clinical practice
June 17, 2025
UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer
UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy.